Recent Advances in the Diagnosis and Treatment of Myocardial Infarction

Dear Colleagues,

Acute myocardial infarction is a major global health concern. In the past decade, significant advancements in its diagnosis and treatment have revolutionized patient care and outcomes. Innovations in diagnostic techniques, such as high-sensitivity cardiac troponin and other biomarkers, have facilitated earlier and more accurate diagnosis, enabling prompt intervention. Furthermore, advanced imaging modalities such as MRI and CT are playing an increasingly vital role in this pathology, enabling the detailed assessment of cardiac structures, aiding in accurate diagnosis, and facilitating risk stratification. Rapid reperfusion remains crucial for improving outcomes. Novel pharmacological treatments, including potent and rapid-action antiplatelet therapies and cholesterol-lowering drugs, have further enhanced the treatment landscape. Additionally, the widespread adoption of a new generation of drug-eluting stents has also contributed to enhanced outcomes. More recently, the emergence of diverse and promising devices for mechanical circulatory support has offered additional resources for patients with a poorer prognosis, although evidence regarding their use remains limited. However, despite these advancements, acute myocardial infarction remains a leading cause of death, underscoring the need for further research and innovation in this exciting field. This Special Issue welcomes the submission of original research and systematic reviews that investigate myocardial infarction, with a particular emphasis on innovations in diagnosis and management approaches.

Dr. David Del Val
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• myocardial infarction
• heart failure
• coronary artery disease
• acute coronary syndromes
• diagnosis
• cardiogenic shock